Cargando…
The relationship between cardiac radiation dose and mediastinal lymph node involvement in stage III non-small cell lung cancer patients
PURPOSE: The results from Radiation Therapy Oncology Group (RTOG) 0617, a dose escalation trial that compared treatment with 60 Gy versus 74 Gy for patients with stage III non-small cell lung cancer (NSCLC), suggested that in these patients, the heart dose from radiation therapy correlates with surv...
Autores principales: | McNew, Laura K., Bowen, Stephen R., Gopan, Olga, Nyflot, Matthew J., Patel, Shilpen A., Zeng, Jing, Rengan, Ramesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514254/ https://www.ncbi.nlm.nih.gov/pubmed/28740931 http://dx.doi.org/10.1016/j.adro.2017.01.008 |
Ejemplares similares
-
Heart Dose and Outcomes in Radiation Treatment for Esophageal Cancer
por: Macomber, Meghan W, et al.
Publicado: (2018) -
Combining machine learning and texture analysis to differentiate mediastinal lymph nodes in lung cancer patients
por: Alves, Allan F. F., et al.
Publicado: (2021) -
Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes
por: Wang, Huan-Huan, et al.
Publicado: (2016) -
Echoendoscopy with elastography in mediastinal lymph nodes
por: Colaiacovo, Rogerio, et al.
Publicado: (2019) -
Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective
por: Bowen, Stephen R, et al.
Publicado: (2012)